Biotechnology Portfolio
Fund
FBIOX
Price as of:
$21.48
+ $0.27
+ 1.27%
Primary Theme
fund company
Name
As of 11/01/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
20.9%
1 yr return
40.8%
3 Yr Avg Return
0.3%
5 Yr Avg Return
9.3%
Net Assets
$4.92 B
Holdings in Top 10
53.2%
52 WEEK LOW AND HIGH
$21.2
N/A
N/A
Expenses
OPERATING FEES
Expense Ratio 0.66%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 46.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 11/01/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
FBIOX - Profile
Distributions
- YTD Total Return 20.9%
- 3 Yr Annualized Total Return 0.3%
- 5 Yr Annualized Total Return 9.3%
- Capital Gain Distribution Frequency Semi-Annually
- Net Income Ratio -0.14%
- Dividend Yield 0.6%
- Dividend Distribution Frequency SemiAnnual
Fund Details
-
Legal NameBiotechnology Portfolio
-
Fund Family NameFidelity Investments
-
Inception DateJan 03, 1994
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerRajiv Kaul
Fund Description
Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Read More
FBIOX - Performance
Return Ranking - Trailing
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 20.9% | -26.9% | 24.4% | 3.77% |
| 1 Yr | 40.8% | -7.8% | 49.2% | 5.66% |
| 3 Yr | 0.3%* | -32.5% | 9.5% | 45.39% |
| 5 Yr | 9.3%* | -4.9% | 13.7% | 34.93% |
| 10 Yr | 7.1%* | 0.1% | 13.3% | 69.37% |
* Annualized
Return Ranking - Calendar
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 9.5% | -12.6% | 19.0% | 11.32% |
| 2022 | -15.9% | -53.9% | 3.2% | 76.32% |
| 2021 | -23.2% | -39.6% | 24.2% | 90.13% |
| 2020 | 14.0% | -13.6% | 178.2% | 51.01% |
| 2019 | 24.5% | 3.8% | 63.8% | 27.07% |
Total Return Ranking - Trailing
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 20.9% | -26.9% | 24.4% | 3.77% |
| 1 Yr | 40.8% | -7.8% | 49.2% | 5.66% |
| 3 Yr | 0.3%* | -32.5% | 9.5% | 45.39% |
| 5 Yr | 9.3%* | -4.9% | 13.7% | 34.93% |
| 10 Yr | 7.1%* | 0.1% | 13.3% | 69.37% |
* Annualized
Total Return Ranking - Calendar
| Period | FBIOX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2023 | 10.1% | -12.6% | 19.0% | 16.35% |
| 2022 | -15.9% | -53.9% | 3.7% | 80.92% |
| 2021 | -12.4% | -33.9% | 26.0% | 90.13% |
| 2020 | 38.3% | -0.7% | 180.6% | 12.75% |
| 2019 | 36.0% | 4.6% | 63.8% | 6.02% |
NAV & Total Return History
FBIOX - Holdings
Concentration Analysis
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Net Assets | 4.92 B | 6.87 M | 47.2 B | 16.35% |
| Number of Holdings | 199 | 26 | 430 | 5.66% |
| Net Assets in Top 10 | 2.66 B | 2.12 M | 22.1 B | 11.32% |
| Weighting of Top 10 | 53.17% | 18.4% | 79.7% | 28.93% |
Top 10 Holdings
- ABBVIE INC 11.43%
- AMGEN INC 9.05%
- KRYSTAL BIOTECH INC 7.31%
- Fidelity Securities Lending Cash Central Fund 5.58%
- REGENERON PHARMACEUTICALS INC 5.20%
- VERTEX PHARMACEUTICALS INC 4.41%
- ALNYLAM PHARMACEUTICALS INC 3.63%
- GILEAD SCIENCES INC 2.61%
- UCB SA 1.97%
- ZEALAND PHARMA A/S 1.97%
Asset Allocation
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| Stocks | 98.81% | 87.34% | 106.13% | 34.59% |
| Cash | 5.84% | 0.00% | 33.01% | 15.09% |
| Preferred Stocks | 1.03% | 0.00% | 7.86% | 20.75% |
| Other | 0.00% | -22.99% | 23.24% | 93.08% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 97.40% |
| Bonds | 0.00% | 0.00% | 12.39% | 98.11% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| Healthcare | 100.00% | 59.26% | 100.00% | 44.81% |
| Utilities | 0.00% | 0.00% | 0.00% | 97.40% |
| Technology | 0.00% | 0.00% | 22.69% | 97.40% |
| Real Estate | 0.00% | 0.00% | 5.89% | 97.40% |
| Industrials | 0.00% | 0.00% | 7.02% | 97.40% |
| Financial Services | 0.00% | 0.00% | 1.60% | 97.40% |
| Energy | 0.00% | 0.00% | 0.00% | 97.40% |
| Communication Services | 0.00% | 0.00% | 9.11% | 97.40% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 97.40% |
| Consumer Cyclical | 0.00% | 0.00% | 1.92% | 97.40% |
| Basic Materials | 0.00% | 0.00% | 7.16% | 97.40% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | FBIOX % Rank | |
|---|---|---|---|---|
| US | 94.29% | 66.06% | 104.41% | 52.20% |
| Non US | 4.52% | 0.00% | 28.87% | 41.51% |
FBIOX - Expenses
Operational Fees
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.66% | 0.08% | 4.48% | 79.87% |
| Management Fee | 0.65% | 0.03% | 1.25% | 45.28% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | 95.12% |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| FBIOX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 46.00% | 0.00% | 238.00% | 45.19% |
FBIOX - Distributions
Dividend Yield Analysis
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.59% | 0.00% | 6.24% | 27.67% |
Dividend Distribution Analysis
| FBIOX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | SemiAnnual | Annual | Quarterly | Annual |
Net Income Ratio Analysis
| FBIOX | Category Low | Category High | FBIOX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.14% | -2.54% | 1.85% | 44.74% |
Capital Gain Distribution Analysis
| FBIOX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Semi-Annually | Annually | Semi-Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Apr 12, 2024 | $0.063 | OrdinaryDividend |
| Dec 27, 2023 | $0.002 | OrdinaryDividend |
| Dec 01, 2023 | $0.078 | OrdinaryDividend |
| Dec 17, 2021 | $1.098 | CapitalGainLongTerm |
| Apr 09, 2021 | $1.703 | OrdinaryDividend |
| Dec 18, 2020 | $3.849 | OrdinaryDividend |
| Apr 08, 2020 | $1.052 | OrdinaryDividend |
| Dec 20, 2019 | $0.034 | OrdinaryDividend |
| Dec 20, 2019 | $1.158 | CapitalGainLongTerm |
| Apr 05, 2019 | $0.772 | CapitalGainLongTerm |
| Dec 14, 2018 | $0.087 | CapitalGainShortTerm |
| Dec 14, 2018 | $1.016 | CapitalGainLongTerm |
| Apr 06, 2018 | $0.881 | CapitalGainLongTerm |
| Dec 01, 2017 | $0.310 | CapitalGainLongTerm |
| Apr 08, 2016 | $0.596 | CapitalGainLongTerm |
| Dec 07, 2015 | $0.956 | CapitalGainLongTerm |
| Apr 13, 2015 | $0.628 | CapitalGainLongTerm |
| Dec 08, 2014 | $2.384 | CapitalGainLongTerm |
| Dec 09, 2013 | $0.041 | CapitalGainLongTerm |
| Apr 15, 2013 | $0.006 | CapitalGainShortTerm |
| Dec 10, 2012 | $0.078 | CapitalGainShortTerm |
| Dec 10, 2012 | $0.035 | CapitalGainLongTerm |
| Apr 16, 2012 | $0.535 | CapitalGainLongTerm |
| Dec 05, 2011 | $0.012 | CapitalGainLongTerm |
| Apr 10, 2000 | $0.096 | CapitalGainShortTerm |
| Apr 10, 2000 | $0.115 | CapitalGainLongTerm |
| Dec 13, 1999 | $0.135 | CapitalGainShortTerm |
| Dec 13, 1999 | $0.135 | CapitalGainLongTerm |
| Apr 05, 1999 | $0.012 | CapitalGainLongTerm |
| Apr 06, 1998 | $0.063 | CapitalGainShortTerm |
| Apr 06, 1998 | $0.114 | CapitalGainLongTerm |
| Dec 15, 1997 | $0.412 | CapitalGainLongTerm |
| Apr 07, 1997 | $0.007 | CapitalGainShortTerm |
| Apr 07, 1997 | $0.052 | CapitalGainLongTerm |
| Dec 13, 1996 | $0.060 | CapitalGainShortTerm |
| Dec 13, 1996 | $0.272 | CapitalGainLongTerm |
| Dec 18, 1995 | $0.007 | OrdinaryDividend |
| Jun 17, 1991 | $0.130 | OrdinaryDividend |
| Dec 17, 1990 | $0.036 | OrdinaryDividend |
FBIOX - Fund Manager Analysis
Managers
Rajiv Kaul
Start Date
Tenure
Tenure Rank
Oct 12, 2005
16.64
16.6%
Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.88 | 0.25 |